Thienamycin, a new beta-lactam antibiotic, exhibited potent, broad-spectrum activity in vitro against gram-negative bacilli and gram-positive cocci, including many isolates resistant to currently available antibiotics. All isolates were inhibited at concentrations les than or equal to 25 yg/ml, with the exception of 12% Ill., abstr. no. 228, 1976). This study was undertaken to confirm these observations and add data which compare this drug with carbenicillin, ticarcillin, and amoxicilhin, which are in current use, and with the investigational drugs apalcillin 
Infection continues to be a major cause of morbidity and mortality in hospitalized patients, especially among compromised hosts. The search for new broad-spectrum drugs with low toxicity continues to be important. Thienamycin, C11H16N204S, is a new, (M-lactam antibiotic which has exhibited potent, broad-spectrum activity against a wide variety of orgaIisms, including isolates exhibiting resistance to several currently available antibiotics (5; H. Kropp, J. S. Kahan, F. M. Kahan, J. Sundelof, G. Darland, and J. Birnbaum, Program Abstr. Intersci. Conf. Antimicrob. Agents Chemother. 16th, Chicago, Ill., abstr. no. 228, 1976) . This study was undertaken to confirm these observations and add data which compare this drug with carbenicillin, ticarcillin, and amoxicilhin, which are in current use, and with the investigational drugs apalcillin (PC-904), mezlocillin, azlocillin, and piperacillin. MATERIALS 
RESULTS
The in vitro activity of thienamycin against gram-negative bacilli and gram-positive cocci in VOL. 15, 1979 comparison with that of carbenicillin, ticarcillin, amoxicillin, apalcillin, mezlocillin, azlocillin, and piperacillin is shown in Table 1 of these isolates were inhibited, whereas only two isolates were inhibited at an antibiotic concentration of 25 ,Ag/ml and an inoculum concentration of 107 celLs per ml. The MBC was similar to the MIC for these isolates. The MIC and MBC for isolates of E. coli increased fivefold or more when the larger inoculum was used. Thieriamycin inhibited all 10 isolates of P. aeruginosa at a concentration.of 12.5 Xg/ml when the irnoculum concentration was 10' cells per ml, whereas only 6 of these isolates were inhibited at a concentration of 25 tg/ml when the inoculum size was increased to 107 cells per ml. Thienamycin was bactericidal against only two of these isolates under the latter conditions. DISCUSSION The results of this study indicate that thienamycin is a potent antibiotic with broad-spectrum activity. This is in agreement with earlier reports (5; Kropp et al., 16th ICAAC, Abstr. no. 228). Also indicated is the greater, activity, in general, of apalcillin, mezlocillin, azlocillin, and piperacillin over that of carbenicillin, ticarcillin, and amoxicillin and the superiority of thienamycin over all of these drugs. Of particular importance is the activity of thienamycin against isolates exhibiting resistance to other drugs.
Thienamycin significantly inhibited isolates of P. aeruginosa and E. coli even irk tests with an inoculum of 107 cells per ml, although its activity against isolates of K. pneumoniae and its bactericidal activity with the larger inoculum were less impressive. In earlier studies, apalcillin, azlocillin, and piperacillin were inactive against all isolates of E. coli, K. pneumoniae, and P. aeruginosa, and mezlocillin was inactive against all isolates of K. pneumoniae with the larger inoculum, even at an antibiotic concentration of 400 ,tg/ml (1) (2) (3) (4) 
